SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-14-000024
Filing Date
2014-09-15
Accepted
2014-09-15 16:05:58
Documents
7
Period of Report
2014-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kofficelease.htm 8-K 24236
2 EXHIBIT - LEASE nephrogenextoweronelease-f.htm EX-99.1 367771
3 image1.jpg GRAPHIC 125391
4 image2.jpg GRAPHIC 94235
5 image4.jpg GRAPHIC 129705
6 image5.jpg GRAPHIC 125505
7 nephrogenextoweronele_image3.jpg GRAPHIC 421322
  Complete submission text file 0001338095-14-000024.txt   1628772
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 141103294
SIC: 2834 Pharmaceutical Preparations